ICD-10 Code C7A.023 | Malignant carcinoid tumor of the transverse colon Symptoms, Diagnosis, Billing

Malignant carcinoid tumor of the transverse colon is a rare neuroendocrine tumor arising from the enterochromaffin cells in the colon. These tumors can secrete serotonin and other hormones, leading to various clinical symptoms. Accurate coding with ICD-10 Code C7A.023 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code C7A.023 for Malignant carcinoid tumor of the transverse colon?

ICD-10 Code C7A.023 specifically identifies malignant carcinoid tumors located in the transverse colon. These tumors are characterized by their neuroendocrine origin and potential for metastasis. This code should be used in clinical documentation and billing when a patient is diagnosed with this specific type of tumor, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.

ICD-10 Code C7A.023 – Clinical Definition and Explanation of Malignant carcinoid tumor of the transverse colon

Malignant carcinoid tumors of the transverse colon are neuroendocrine tumors that can lead to significant morbidity due to their potential for metastasis and hormone secretion. These tumors often require prompt medical attention for diagnosis and treatment to improve patient outcomes.

Key Clinical Features:

• May present with abdominal pain or obstruction
• Can cause flushing and diarrhea due to serotonin secretion
• Often diagnosed via imaging and biopsy
• Higher incidence in patients with multiple endocrine neoplasia (MEN) syndrome

ICD-10 Code C7A.023 for Malignant carcinoid tumor of the transverse colon – SOAP Notes & Clinical Use

ICD-10 Code C7A.023 is utilized in SOAP notes to document the presence of a malignant carcinoid tumor of the transverse colon. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.

What Does ICD-10 Code C7A.023 for Malignant carcinoid tumor of the transverse colon Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C7A.023 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of malignant carcinoid tumor of the transverse colon. This code supports continuity of care, facilitates accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C7A.023 – Malignant carcinoid tumor of the transverse colon

Management of malignant carcinoid tumors of the transverse colon often requires hospitalization for surgical intervention and supportive care.

Antibiotic Therapy:

• Not typically indicated unless secondary infection occurs
• Consider broad-spectrum antibiotics if infection is suspected
• Duration based on clinical response and culture results

Supportive Care:

• Symptom management for flushing and diarrhea
• Nutritional support as needed
• Pain management protocols

Infection Control:

• Standard precautions during hospitalization
• Monitor for signs of infection post-surgery
• Educate staff on handling patients with neuroendocrine tumors

How to Document Symptoms of Malignant carcinoid tumor of the transverse colon (ICD-10 C7A.023) in SOAP Notes

Subjective:

• Patient reports intermittent abdominal pain
• Complains of episodes of flushing and diarrhea
• History of weight loss over the past few months
• No known family history of colorectal cancer

Objective:

• Abdominal tenderness on palpation
• Imaging shows a mass in the transverse colon
• Elevated serotonin levels in blood tests
• Biopsy confirms malignant carcinoid tumor

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Malignant carcinoid tumor of the transverse colon (ICD-10 Code C7A.023)

Assessment:

• Diagnosis: Malignant carcinoid tumor of the transverse colon, moderate severity
• ICD-10 Code: C7A.023
• Contributing factors: Possible genetic predisposition
• Monitor for potential metastasis

Plan:

• Refer to oncology for surgical evaluation
• Consider somatostatin analogs for symptom management
• Educate patient on dietary modifications
• Schedule follow-up imaging to assess tumor progression

Treatment & Plan Section for ICD-10 Code C7A.023 – Malignant carcinoid tumor of the transverse colon

• Surgical resection is the primary treatment option
• Somatostatin analogs may be used to control symptoms
• Regular follow-up with imaging to monitor for recurrence
• Nutritional counseling to address weight loss and dietary needs

Using ICD-10 Code C7A.023 for Malignant carcinoid tumor of the transverse colon in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and findings in SOAP notes
• Use C7A.023 in conjunction with relevant CPT codes for billing
• Maintain compliance with coding guidelines to support reimbursement
• Document treatment plans that align with clinical guidelines

Related ICD-10 Codes Often Used with Malignant carcinoid tumor of the transverse colon

• C7A.024 – Malignant carcinoid tumor of the ascending colon
• C7A.025 – Malignant carcinoid tumor of the descending colon
• C7A.026 – Malignant carcinoid tumor of the sigmoid colon

ICD-10 Code C7A.023 in Medical Billing and Insurance for Malignant carcinoid tumor of the transverse colon

ICD-10 Code C7A.023 is critical for accurate billing in hospital, ER, or oncology settings.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis
• Use C7A.023 in appropriate settings to ensure proper reimbursement
• Include detailed treatment plans in the medical record

Common CPT Pairings: